ClinicalTrials.Veeva

Find clinical trials for Pancreatic Cancer in Durham, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Lung Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Durham, NC, USA:

Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer

This is a single arm study evaluating the tolerability and markers of pancreatic cancer with a specially designed medical food rest...

Enrolling
Metastatic Pancreatic Adenocarcinoma
Locally Advanced Unresectable Pancreatic Adenocarcinoma
Other: NEAAR Medical Food
Faeth Therapeutics

Raleigh, North Carolina, United States and 11 other locations

This phase I study is designed to establish the safety, maximally tolerated dose (MTD) and recommended phase II dose (RP2D) of the ERK inhibitor ulix...

Enrolling
Pancreatic Cancer
Melanoma
Drug: Palbociclib
Drug: Ulixertinib

Phase 1

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, United States

This trial will study tisotumab vedotin to find out whether it is an effective treatment for certain solid tumors and what side effects (unwanted eff...

Enrolling
Exocrine Pancreatic Cancer
Carcinoma, Non-Small-Cell Lung
Drug: cisplatin
Drug: carboplatin

Phase 2

Seagen
Seagen

Chapel Hill, North Carolina, United States and 60 other locations

immune system to attack the tumor.ASP2138 is a potential new treatment for people with stomach cancer, gastroesophageal junction cancer...

Enrolling
Pancreatic Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
Drug: ASP2138

Phase 1

Astellas
Astellas

Durham, North Carolina, United States and 21 other locations

given to participants. Part C will use the information from Parts A and B to see if SGN-BB228 is safe and if it works to treat solid tumor cancers...

Enrolling
Non-small Cell Lung Cancer
Pancreatic Neoplasms
Drug: SGN-BB228

Phase 1

Seagen
Seagen

Durham, North Carolina, United States and 17 other locations

assess a potential correlation between tumor infiltrating lymphocytes (TILs) and clinical benefits in participants with CPI-naïve R/R ovarian cancer...

Active, not recruiting
Small Cell Lung Cancer
Non Small Cell Lung Cancer
Drug: NT-I7
Drug: pembrolizumab (KEYTRUDA®)

Phase 1, Phase 2

NeoImmuneTech

Durham, North Carolina, United States and 7 other locations

and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers...

Active, not recruiting
Neoplasms Pancreatic
Pancreatic Adenocarcinoma
Drug: Gemcitabine - 21 day cycle
Drug: Lomustine

Phase 2

Actuate Therapeutics

Durham, North Carolina, United States and 65 other locations

Subjects with selected solid tumors including non-small cell lung cancer (NSCLC) who have a tumor lesion which is accessible for injection w...

Enrolling
Metastatic Cancer
Advanced Cancer
Biological: MEM-288 Intratumoral Injection
Biological: Nivolumab

Phase 1

Memgen

Durham, North Carolina, United States and 1 other location

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...

Active, not recruiting
Breast Cancer
Papillary Thyroid Cancer
Drug: Entrectinib

Phase 2

Roche
Roche

Durham, North Carolina, United States and 122 other locations

This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb23104, to describe safety and tolerability, t...

Active, not recruiting
Small Cell Lung Cancer
Pancreatic Carcinoma
Biological: Yervoy® (ipilimumab)
Biological: XmAb®23104

Phase 1

Xencor
Xencor

Durham, North Carolina, United States and 17 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems